Belinostat Clinical Trials
5 recruitingDrug
Phase 22Phase 32Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 2
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Carcinoma, NeuroendocrineTumor, NeuroendocrineTumors, Neuroendocrine
National Cancer Institute (NCI)60 enrolled1 locationNCT06406465
Recruiting
Phase 3
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Lymphoma, T-CellPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell Lymphoma+4 more
Corvus Pharmaceuticals, Inc.150 enrolled34 locationsNCT06561048
Recruiting
Phase 2
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
PTCL
University of Virginia50 enrolled6 locationsNCT04747236
Recruiting
Phase 3
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
Dizal Pharmaceuticals218 enrolled50 locationsNCT07234162
Recruiting
Phase 1
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics
Metastatic Breast CancerRecurrent Ovarian Carcinoma
University of Utah34 enrolled2 locationsNCT04315233